| Imiquimod tested as cervical dysplasia therapy. (Immune-Response Modifiers).: An article from: Internal Medicine News | Digitalby Mitchel L. Zoler (Author)
| List Price: | $5.95 | | | Available: | Available for download now |
| | Binding: | Digital | | Publisher: | International Medical News Group | | Page Count: | 2 Pages | | Publication Date: | February 15, 2002 | | Sales Rank: | 7,387,847th |
|
EDITORIAL REVIEWS |
Product Description
This digital document is an article from Internal Medicine News, published by International Medical News Group on February 15, 2002. The length of the article is 569 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Imiquimod tested as cervical dysplasia therapy. (Immune-Response Modifiers).Author: Mitchel L. ZolerPublication: Internal Medicine News (Magazine/Journal)Date: February 15, 2002Publisher: International Medical News GroupVolume: 35 Issue: 4 Page: 20(1)Distributed by Thomson Gale |
|
